Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Hazzan

Showing results (51-60 of 120) with videos related to

Pageof 12
Sort By:
Transplant International : Official Journal of the European Society for Organ Transplantation|September 22, 2007
Evolution of immunoglobulin and mannose binding protein levels after renal transplantation: association with infectious complicationsEmine Nilufer Broeders, Karl Martin Wissing, Marc Hazzan, et al.
Transplantation|July 27, 2022
Association Between Maintenance Immunosuppressive Regimens and COVID-19 Mortality in Kidney Transplant RecipientsAlexandre O Gérard, Susana Barbosa, Dany Anglicheau, et al.
Scientific Reports|June 10, 2021
Impaired renal function before kidney procurement has a deleterious impact on allograft survival in very old deceased kidney donorsMehdi Maanaoui, François Provôt, Sébastien Bouyé, et al.
Clinical Transplantation|September 14, 2016
Long-term outcome after early cyclosporine withdrawal in kidney transplantation: ten years afterNahid Tabibzadeh, François Glowacki, Marie Frimat, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 17, 2011
CYP3A5 and ABCB1 polymorphisms in donor and recipient: impact on Tacrolimus dose requirements and clinical outcome after renal transplantationFrançois Glowacki, Arnaud Lionet, David Buob, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 8, 2009
Reviving function in CD4+ T cells adapted to persistent systemic antigenMagali Noval Rivas, Kathleen Weatherly, Marc Hazzan, et al.
Journal of Clinical Medicine|June 2, 2021
Day-Time Declamping Is Associated with Better Outcomes in Kidney Transplantation: The Circarein StudyDavid Montaigne, Nasser Alhawajri, Mathilde Jacquelinet, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|April 11, 2012
Three-year outcome of isolated glomerulitis on 3-month protocol biopsies of donor HLA antibody negative patientsDavid Buob, Philippe Grimbert, François Glowacki, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|April 17, 2015
Access to preemptive registration on the waiting list for renal transplantation: a hierarchical modeling approachNatacha Riffaut, Thierry Lobbedez, Marc Hazzan, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 8, 2014
Strategies to increase the donor pool and access to kidney transplantation: an international perspectiveUmberto Maggiore, Rainer Oberbauer, Julio Pascual, et al.
Pageof 12

Showing results (51-60 of 120) with videos related to

Sort By:
Pageof 12
Transplant International : Official Journal of the European Society for Organ Transplantation|September 22, 2007
Evolution of immunoglobulin and mannose binding protein levels after renal transplantation: association with infectious complicationsEmine Nilufer Broeders, Karl Martin Wissing, Marc Hazzan, et al.
Transplantation|July 27, 2022
Association Between Maintenance Immunosuppressive Regimens and COVID-19 Mortality in Kidney Transplant RecipientsAlexandre O Gérard, Susana Barbosa, Dany Anglicheau, et al.
Scientific Reports|June 10, 2021
Impaired renal function before kidney procurement has a deleterious impact on allograft survival in very old deceased kidney donorsMehdi Maanaoui, François Provôt, Sébastien Bouyé, et al.
Clinical Transplantation|September 14, 2016
Long-term outcome after early cyclosporine withdrawal in kidney transplantation: ten years afterNahid Tabibzadeh, François Glowacki, Marie Frimat, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 17, 2011
CYP3A5 and ABCB1 polymorphisms in donor and recipient: impact on Tacrolimus dose requirements and clinical outcome after renal transplantationFrançois Glowacki, Arnaud Lionet, David Buob, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 8, 2009
Reviving function in CD4+ T cells adapted to persistent systemic antigenMagali Noval Rivas, Kathleen Weatherly, Marc Hazzan, et al.
Journal of Clinical Medicine|June 2, 2021
Day-Time Declamping Is Associated with Better Outcomes in Kidney Transplantation: The Circarein StudyDavid Montaigne, Nasser Alhawajri, Mathilde Jacquelinet, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|April 11, 2012
Three-year outcome of isolated glomerulitis on 3-month protocol biopsies of donor HLA antibody negative patientsDavid Buob, Philippe Grimbert, François Glowacki, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|April 17, 2015
Access to preemptive registration on the waiting list for renal transplantation: a hierarchical modeling approachNatacha Riffaut, Thierry Lobbedez, Marc Hazzan, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 8, 2014
Strategies to increase the donor pool and access to kidney transplantation: an international perspectiveUmberto Maggiore, Rainer Oberbauer, Julio Pascual, et al.
Pageof 12